Literature DB >> 11819458

Codon 249 mutations of p53 gene in non-neoplastic liver tissues.

Xiao-Mou Peng, Chun-Lan Yao, Xue-Juan Chen, Wen-Wei Peng, Zhi-Liang Gao.   

Abstract

AIM:To study the significance of p53 gene in hepatocarcinogenesis through analyzing codon 249 mutations of p53 gene in non-neoplastic liver tissues.
METHODS: Codon 249 mutation was detected using single-stranded conformational polymorphism analysis and allele-specific PCR in liver tissues from 10 cases of chronic hepatitis, 5 cases of cirrhosis and 20 cases of HCCs.
RESULTS: The detection rate of codon 249 mutation in chronic hepatitis, cirrhosis and pericancerous tissues was 70% (7/10), 100% (5/5) and 70% (14/20), respectively by AS-PCR. These mutations could not be detected by SSCP analysis. The detection rates were 65% (13/20) and 45% (9/20) in cancerous tissues by AS-PCR and SSCP analysis.
CONCLUSION: Codon 249 mutations of p53 gene were very popular in non-neoplastic liver tissues though the number of those mutant cells was only in subsection. Those mutations in cancerous tissues might take place in the stage before the formation of tumor.

Entities:  

Year:  1999        PMID: 11819458      PMCID: PMC4695545          DOI: 10.3748/wjg.v5.i4.324

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  9 in total

Review 1.  Alteration of cell cycle-related genes in hepatocarcinogenesis.

Authors:  N Nishida; Y Fukuda; K Ishizaki; K Nakao
Journal:  Histol Histopathol       Date:  1997-10       Impact factor: 2.303

2.  Allele-specific PCR analysis of p53 codon 249 AGT transversion in liver tissues from patients with viral hepatitis.

Authors:  G M Kirby; G Batist; N Fotouhi-Ardakani; H Nakazawa; H Yamasaki; M Kew; R G Cameron; M A Alaoui-Jamali
Journal:  Int J Cancer       Date:  1996-09-27       Impact factor: 7.396

3.  Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa.

Authors:  B Bressac; M Kew; J Wands; M Ozturk
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

4.  Aflatoxin B1 induces the transversion of G-->T in codon 249 of the p53 tumor suppressor gene in human hepatocytes.

Authors:  F Aguilar; S P Hussain; P Cerutti
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

5.  p53 mutations and hepatitis B virus: cofactors in hepatocellular carcinoma.

Authors:  B L Slagle
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

6.  Control of mouse hepatocyte proliferation and ploidy by p53 and p53ser246 mutation in vivo.

Authors:  L Yin; N Ghebranious; S Chakraborty; C E Sheehan; Z Ilic; S Sell
Journal:  Hepatology       Date:  1998-01       Impact factor: 17.425

7.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

Review 8.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

9.  Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.

Authors:  Y Murakami; K Hayashi; S Hirohashi; T Sekiya
Journal:  Cancer Res       Date:  1991-10-15       Impact factor: 12.701

  9 in total
  7 in total

1.  Plasma endothelin in patients with endotoxemia and dynamic comparison between vasoconstrictor and vasodilator in cirrhotic patients.

Authors:  F Liu; J X Li; C M Li; X S Leng
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Infrequent p53 gene mutation and expression of the cardia adenocarcinomas from a high-incidence area of Southwest China.

Authors:  Xiu-Jie Wang; Shu-Lan Yuan; Chang-Ping Li; Naoko Iida; Hideaki Oda; Shigetoshi Aiso; Takatoshi Ishikawa
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

3.  Rapid screening mitochondrial DNA mutation by using denaturing high-performance liquid chromatography.

Authors:  Man-Ran Liu; Kai-Feng Pan; Zhen-Fu Li; Yi Wang; Da-Jun Deng; Lian Zhang; You-Yong Lu
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

4.  Somatic mutation analysis of p53 and ST7 tumor suppressor genes in gastric carcinoma by DHPLC.

Authors:  Chong Lu; Hui-Mian Xu; Qun Ren; Yang Ao; Zhen-Ning Wang; Xue Ao; Li Jiang; Yang Luo; Xue Zhang
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

5.  Novel assay of competitively differentiated polymerase chain reaction for screening point mutation of hepatitis B virus.

Authors:  Xiao-Mou Peng; Xue-Juan Chen; Jian-Guo Li; Lin Gu; Yang-Su Huang; Zhi-Liang Gao
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

6.  Hepatocellular carcinoma and liver cirrhosis TP53 mutation analysis reflects a moderate dietary exposure to aflatoxins in Espírito Santo State, Brazil.

Authors:  Fernanda Magri de Carvalho; Thiago de Almeida Pereira; Patrícia Lofego Gonçalves; Robson Dettmann Jarske; Fausto Edmundo Lima Pereira; Iuri Drumond Louro
Journal:  Mol Biol Rep       Date:  2013-05-07       Impact factor: 2.316

7.  Mutation analysis of novel human liver-related putative tumor suppressor gene in hepatocellular carcinoma.

Authors:  Cheng Liao; Mu-Jun Zhao; Jing Zhao; Hai Song; Pascal Pineau; Agnes Marchio; Anne Dejean; Pierre Tiollais; Hong-Yang Wang; Tsai-Ping Li
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.